Fisher, BA; Mariette, X; Papas, AS; Grader-Beck, T; Bootsma, H; Ng, WF; Van Daele, P; Finzel, S; Elgueta, S; Hermann, J; Mccoy, S; Bookman, A; Sopala, M; Luo, WL; Scheurer, C; Hueber, W.
Iscalimab (CFZ533) in Patients with Sjogren's Disease: Week 24 Efficacy and Safety Results of a Randomized, Placebo-controlled, Phase 2b Dose-ranging Study
ARTHRITIS RHEUMATOL. 2023; 75: 3242-3244.-2023 American College of Rheumatology Annual Meeting.; Nov, 12-15, 2023; San Diego, California.
[Oral Communication]
Web of Science